Brian Bronk

Brian joined Satori in 2009. Brian previously was with Pfizer where he held a series of positions of increasing responsibility and was most recently Senior Director of Medicinal Chemistry. During his time at Pfizer, his responsibilities focused on leading synthetic and computational medicinal chemistry and multi-disciplinary research teams to deliver clinical candidates for multiple diseases, including psychiatry, neurology, infectious diseases and metabolic disorders. By focusing on innovation and collaboration, his teams were involved in the discovery of more than a dozen development candidates, including the launched products Draxxin, Convenia, Cerina and Slentrol. Brian earned his B.A. from Colgate University in 1989. Following a year in Dortmund, Germany as a Fulbright Fellow, he initiated his doctoral work at MIT and received his Ph.D. in Chemistry in 1994.